Activation of CMKLR1 by chemerin has well‐established roles in inflammation, adipogenesis, and insulin sensitivity, and thus chemerin has a firm role in the pathology of obesity and metabolic syndrome.1 There is increasing recognition of the association between metabolic syndrome and cardiovascular disease. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.